Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0187 Transporter Info | ||||
Gene Name | SLC25A26 | ||||
Transporter Name | S-adenosylmethionine mitochondrial carrier protein | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 results in decreased methylation of SLC25A26 intron | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Chemical Compound |
|||||
DT Modulation1 |
Valproic Acid affects the expression of SLC25A26 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
aristolochic acid I |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aristolochic acid I results in decreased expression of SLC25A26 mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC25A26 exon | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-lapachone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-lapachone results in increased expression of SLC25A26 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-methylcholine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-methylcholine affects the expression of SLC25A26 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC25A26 gene | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol A results in decreased methylation of SLC25A26 gene | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
dicrotophos results in decreased expression of SLC25A26 mRNA | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fulvestrant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC25A26 gene | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Thiram results in decreased expression of SLC25A26 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate inhibits the expression of SLC25A26 | [1] | |||
Amiodarone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Amiodarone increases the expression of SLC25A26 | [2] | |||
Rosiglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rosiglitazone increases the expression of SLC25A26 | [3] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine increases the expression of SLC25A26 | [4] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC25A26 | [5] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin increases the expression of SLC25A26 | [6] | |||
Patented Pharmaceutical Agent |
|||||
GSK-J4 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
GSK-J4 increases the expression of SLC25A26 | [10] | |||
Cyanotoxin |
|||||
Cylindrospermopsin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cylindrospermopsin increases the expression of SLC25A26 | [8] | |||
cylindrospermopsin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
cylindrospermopsin results in increased expression of SLC25A26 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dicrotophos inhibits the expression of SLC25A26 | [9] | |||
Herbicide |
|||||
Atrazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Atrazine inhibits the expression of SLC25A26 | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.